tiprankstipranks
BioArctic AB Class B (GB:0RV2)
LSE:0RV2
UK Market

BioArctic AB Class B (0RV2) Share Forecast & Price Target

5 Followers
See the Price Targets and Ratings of:

0RV2 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
BioArctic
AB Class B
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0RV2 Stock 12 Month Forecast

There Are No Analyst Ratings for GB:0RV2 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

0RV2 Financial Forecast

0RV2 Earnings Forecast

Next quarter’s earnings estimate for 0RV2 is kr0.22 with a range of kr0.20 to kr0.24. The previous quarter’s EPS was -kr0.13. 0RV2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0RV2 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0RV2 is kr0.22 with a range of kr0.20 to kr0.24. The previous quarter’s EPS was -kr0.13. 0RV2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0RV2 has Performed in-line its overall industry.

0RV2 Sales Forecast

Next quarter’s sales forecast for 0RV2 is kr291.96M with a range of kr260.00M to kr310.00M. The previous quarter’s sales results were kr247.53M. 0RV2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0RV2 has Performed in-line its overall industry.
Next quarter’s sales forecast for 0RV2 is kr291.96M with a range of kr260.00M to kr310.00M. The previous quarter’s sales results were kr247.53M. 0RV2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0RV2 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - OpenAI Analyst forecast on GB:0RV2
TipRanks - OpenAI
TipRanks - OpenAI
kr371kr356
Hold
10.43%
Upside
Downgraded
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on GB:0RV2
TipRanks - DeepSeek
TipRanks - DeepSeek
kr368kr345
Hold
7.02%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on GB:0RV2
TipRanks - xAI
TipRanks - xAI
kr381kr363
Buy
12.60%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on GB:0RV2
TipRanks - Google
TipRanks - Google
kr384kr366
Buy
13.53%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on GB:0RV2
TipRanks - Anthropic
TipRanks - Anthropic
kr361kr350
Hold
8.57%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on GB:0RV2
TipRanks - PerPlexity
TipRanks - PerPlexity
kr366kr360
Buy
11.67%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - OpenAI Analyst forecast on GB:0RV2
TipRanks - OpenAI
TipRanks - OpenAI
kr371kr356
Hold
10.43%
Upside
Downgraded
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on GB:0RV2
TipRanks - DeepSeek
TipRanks - DeepSeek
kr368kr345
Hold
7.02%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on GB:0RV2
TipRanks - xAI
TipRanks - xAI
kr381kr363
Buy
12.60%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on GB:0RV2
TipRanks - Google
TipRanks - Google
kr384kr366
Buy
13.53%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on GB:0RV2
TipRanks - Anthropic
TipRanks - Anthropic
kr361kr350
Hold
8.57%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on GB:0RV2
TipRanks - PerPlexity
TipRanks - PerPlexity
kr366kr360
Buy
11.67%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioArctic AB Class B

3 Months
PerPlexity Health Care EUTipRanks - PerPlexity
Success Rate
1/1 ratings generated profit
100%
Average Return
+58.00%
Copying PerPlexity Health Care EU's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +58.00% per trade.
1 Year
PerPlexity Health Care EUTipRanks - PerPlexity
Success Rate
1/1 ratings generated profit
100%
Average Return
+59.90%
Copying PerPlexity Health Care EU's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +59.90% per trade.
2 Years
PerPlexity Health Care EUTipRanks - PerPlexity
Success Rate
1/1 ratings generated profit
100%
Average Return
+82.90%
Copying PerPlexity Health Care EU's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +82.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0RV2 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, 0RV2 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0RV2 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

0RV2 Stock Forecast FAQ

What is GB:0RV2’s average 12-month price target, according to analysts?
Currently, no data Available
What is GB:0RV2’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0RV2, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is BioArctic AB Class B a Buy, Sell or Hold?
      Currently, no data Available
      What is BioArctic AB Class B’s share price target?
      Currently, no data Available
      What do analysts say about BioArctic AB Class B?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of BioArctic AB Class B?
      To buy shares of GB:0RV2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.